173 related articles for article (PubMed ID: 12899642)
1. Selective replicating viral vectors : potential for use in cancer gene therapy.
Nemunaitis J
BioDrugs; 2003; 17(4):251-62. PubMed ID: 12899642
[TBL] [Abstract][Full Text] [Related]
2. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
3. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
4. Replicating adenoviruses in cancer therapy.
Dobbelstein M
Curr Top Microbiol Immunol; 2004; 273():291-334. PubMed ID: 14674605
[TBL] [Abstract][Full Text] [Related]
5. Replicating herpes simplex virus vectors for cancer gene therapy.
Yeung SN; Tufaro F
Expert Opin Pharmacother; 2000 May; 1(4):623-31. PubMed ID: 11249507
[TBL] [Abstract][Full Text] [Related]
6. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
Wildner O; Morris JC
Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
[TBL] [Abstract][Full Text] [Related]
7. Head and neck cancer: gene therapy approaches. Part 1: adenoviral vectors.
Nemunaitis J; O'Brien J
Expert Opin Biol Ther; 2002 Feb; 2(2):177-85. PubMed ID: 11849117
[TBL] [Abstract][Full Text] [Related]
8. Targeting the replication of adenoviral gene therapy vectors to lung cancer cells: the importance of the adenoviral E1b-55kD gene.
Hay JG; Shapiro N; Sauthoff H; Heitner S; Phupakdi W; Rom WN
Hum Gene Ther; 1999 Mar; 10(4):579-90. PubMed ID: 10094201
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.
Kim J; Cho JY; Kim JH; Jung KC; Yun CO
Cancer Gene Ther; 2002 Sep; 9(9):725-36. PubMed ID: 12189522
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
11. Gene delivery using herpes simplex virus vectors.
Burton EA; Fink DJ; Glorioso JC
DNA Cell Biol; 2002 Dec; 21(12):915-36. PubMed ID: 12573050
[TBL] [Abstract][Full Text] [Related]
12. Viral-mediated gene transfer for cancer treatment.
Wilson DR
Curr Pharm Biotechnol; 2002 Jun; 3(2):151-64. PubMed ID: 12022258
[TBL] [Abstract][Full Text] [Related]
13. Selectively replicating adenoviruses for oncolytic therapy.
Yoon TK; Shichinohe T; Laquerre S; Kasahara N
Curr Cancer Drug Targets; 2001 Aug; 1(2):85-107. PubMed ID: 12188883
[TBL] [Abstract][Full Text] [Related]
14. [Gene therapy and molecular therapeutic for head and neck cancer].
Tanaka H
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2046-51. PubMed ID: 16352927
[TBL] [Abstract][Full Text] [Related]
15. Gene transfer with herpes simplex vectors.
Lachmann RH; Efstathiou S
Curr Opin Mol Ther; 1999 Oct; 1(5):622-32. PubMed ID: 11249669
[TBL] [Abstract][Full Text] [Related]
16. Development of a second-generation oncolytic Herpes simplex virus expressing TNFalpha for cancer therapy.
Han ZQ; Assenberg M; Liu BL; Wang YB; Simpson G; Thomas S; Coffin RS
J Gene Med; 2007 Feb; 9(2):99-106. PubMed ID: 17256802
[TBL] [Abstract][Full Text] [Related]
17. Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors.
Galanis E; Vile R; Russell SJ
Crit Rev Oncol Hematol; 2001 Jun; 38(3):177-92. PubMed ID: 11369253
[TBL] [Abstract][Full Text] [Related]
18. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.
Sterman DH; Treat J; Litzky LA; Amin KM; Coonrod L; Molnar-Kimber K; Recio A; Knox L; Wilson JM; Albelda SM; Kaiser LR
Hum Gene Ther; 1998 May; 9(7):1083-92. PubMed ID: 9607419
[TBL] [Abstract][Full Text] [Related]
20. Vaccinia as a vector for gene delivery.
Guo ZS; Bartlett DL
Expert Opin Biol Ther; 2004 Jun; 4(6):901-17. PubMed ID: 15174972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
